HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- (5- benzo(1,3)dioxol- 5- yl- 2- tert- butyl- 3H- imidazol- 4- yl)- 6- methylpyridine hydrochloride

a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7
Also Known As:
SB-505124
Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Nakamura, Hiroshi: 2 articles (07/2013 - 01/2010)
2. Tang, Ming-Jer: 1 article (01/2014)
3. Chiu, Pei-Hung: 1 article (01/2014)
4. Wu, Tsung-Hsien: 1 article (01/2014)
5. Chou, Yu-Wei: 1 article (01/2014)
6. Hu, Chun-Wen: 1 article (01/2014)
7. Yeh, Ming-Long: 1 article (01/2014)
8. Geldenhuys, Werner: 1 article (07/2013)
9. Miladore, Nicholas: 1 article (07/2013)
10. Wehrung, Daniel: 1 article (07/2013)

Related Diseases

1. Glaucoma
2. Lewis Lung Carcinoma
3. Wounds and Injuries (Trauma)
4. Strabismus (Squint)
5. Pancreatic Neoplasms (Pancreatic Cancer)

Related Drugs and Biologics

1. Poloxamer (Poloxamer 407)
2. TGF-beta type I receptor
3. Activins (Activin)
4. Mitomycin (Mitomycin-C)
5. Ligands
6. 6- acetyl- 8- cyclopentyl- 5- methyl- 2- (5- piperazin- 1- ylpyridin- 2- ylamino)- 8H- pyrido(2,3- d)pyrimidin- 7- one

Related Therapies and Procedures

1. Filtering Surgery